Luigi Mangione admitted in federal court Friday that he shot UnitedHealthcare CEO Brian Thompson, pleading guilty to the two remaining federal stalking charges connected to Thompson’s December 2024 killing in Manhattan.
The plea resolves Mangione’s federal case without a trial, but it does not end the wider legal battle. He could receive life in federal prison when he is sentenced on December 18. His lawyers are also seeking to dismiss a separate New York murder prosecution under the state’s double-jeopardy law.
What Luigi Mangione admitted in court
Mangione did more than enter a guilty plea. He described his actions to U.S. District Judge Margaret Garnett and acknowledged that he knew what he was doing was illegal.
Mangione said that after years of severe pain following a broken back, he learned UnitedHealth would hold an investor conference in New York. He researched the event and said he contacted UnitedHealthcare while posing as an investor with more than $50 million in capital to obtain information about the conference.
He then traveled to New York intending to kill Thompson and admitted shooting him in the back.
Thompson was killed on December 4, 2024, while heading to UnitedHealth Group’s investor conference in Midtown Manhattan. Mangione was arrested in Pennsylvania five days later following a manhunt.
No plea agreement and a possible life sentence
Mangione pleaded guilty to stalking involving interstate travel and stalking involving the use of interstate facilities. Judge Garnett accepted the pleas after confirming that he understood he was giving up his right to a federal trial.
There was no plea agreement with federal prosecutors. Mangione told the court he had not been promised a particular outcome and had not been threatened or coerced.
The judge told Mangione that the guilty plea could expose him to a life sentence. His federal sentencing is scheduled for December 18, 2026.
The case had previously included federal murder and firearm charges. Judge Garnett dismissed those counts in January 2026, removing the possibility of a federal death sentence while allowing the two stalking charges to continue.
The federal court’s January opinion explains the legal reasoning that narrowed the prosecution.
Could New York’s murder case be dismissed?
This is now the biggest unresolved question. Mangione’s attorneys filed a motion seeking dismissal of the remaining state charges under New York’s double-jeopardy protections.
The defense argues that Mangione has accepted responsibility for Thompson’s death and should not be prosecuted again over the same conduct. Manhattan prosecutors disagree, maintaining that the federal stalking offenses and state murder case address different legal harms.
The issue is more complicated than the general rule allowing federal and state governments to pursue separate prosecutions. New York has additional statutory protections governing successive prosecutions, leaving the state judge to determine whether they apply here.
Unless the motion succeeds or the schedule changes, Mangione’s New York trial is set to begin September 8, 2026.
Optus Triple Zero Outage Fine: Latest Update
What charges remain in New York?
Mangione still faces second-degree murder, second-degree criminal possession of a forged instrument and multiple weapons charges.
The state case has already been narrowed. Judge Gregory Carro dismissed first-degree murder and terrorism charges in September 2025 while allowing the second-degree murder prosecution to continue.
The case has also kept attention on UnitedHealthcare and parent company UnitedHealth Group. The insurer has been navigating changes across its core business, including Medicare Advantage pricing and medical costs, explored in our analysis of UnitedHealth’s managed-care recovery and UNH stock.
UnitedHealthcare’s policies also directly affect patients and providers across the country. A separate UnitedHealthcare payment dispute involving Lakeland doctors and patients illustrates how reimbursement and provider-network negotiations can create uncertainty over access to in-network care.
Brian Thompson’s family attends the hearing
Thompson’s wife, mother and other relatives attended Friday’s proceeding, marking their first reported courtroom appearance in the case. His wife watched Mangione answer the judge’s questions and became emotional as prosecutors described evidence they would have presented at trial.
Thompson’s family said afterward that the guilty plea represented an important step toward justice while stressing that nothing could erase the pain of losing him.
Thompson, 50, had spent roughly two decades at UnitedHealth Group and became CEO of UnitedHealthcare in 2021.
Two dates now shape the case. The New York murder trial is currently scheduled for September 8, although the double-jeopardy motion could determine whether it proceeds. Mangione’s federal sentencing follows on December 18, when he could receive up to life imprisonment.
Friday’s plea establishes Mangione’s admission to shooting Thompson and resolves the remaining federal charges. What remains unsettled is whether New York can separately prosecute him for murder, making the state court’s decision the next major development to watch.
Make Swikblog your go-to source on Google for reliable updates, smart insights, and daily trends.
